{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:51Z","timestamp":1787025891436,"version":"build-2736575974"},"reference-count":65,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,3,7]]},"abstract":"<jats:p>Background: The primary manifestations of Alzheimer\u2019s disease (AD) include cognitive decline and brain gray matter volume (GMV) atrophy. Recent studies have found that plasma phosphorylated-tau (p-tau) concentrations perform better in diagnosing, differentiating, and monitoring the progression of AD. However, the correlation between plasma p-tau, GMV, and cognition remains unclear. Objective: To investigate whether GMV plays a mediating role in the association between plasma p-tau concentrations and cognition. Methods: In total, 99 participants (47 patients with AD and 52 cognitively unimpaired [CU] individuals) were included. All participants underwent neuropsychological assessments, laboratory examinations, and magnetic resonance imaging scans. Plasma p-tau217 and p-tau181 concentrations were measured using an enzyme-linked immunosorbent assay kit. Voxel-based morphometry was performed to assess participants\u2019 brain GMV. Partial correlation and mediation analyses were conducted in AD group. Results: Plasma p-tau concentrations were significantly higher in the AD group than in the CU group. Patients with AD had significant brain GMV atrophy in the right hippocampus, bilateral middle temporal gyrus, and right inferior temporal gyrus. In the AD group, there were significant correlations between plasma p-tau217 concentrations, GMV, and Mini-Mental State Examination (MMSE) scores. Brain GMV of the right hippocampus mediated the association between plasma p-tau217 concentrations and MMSE scores. A significant correlation between plasma p-tau181 and MMSE scores was not identified. Conclusion: The findings indicate that p-tau217 is a promising biomarker for central processes affecting brain GMV and cognitive function. This may provide potential targets for future intervention and treatment of tau-targeting therapies in the early stages of AD.<\/jats:p>","DOI":"10.3233\/jad-221100","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T11:46:56Z","timestamp":1674820016000},"page":"81-93","source":"Crossref","is-referenced-by-count":8,"title":["Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer\u2019s Disease in China: A Cross-Sectional Observational Study"],"prefix":"10.1177","volume":"92","author":[{"given":"Ke","family":"Wan","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-221100_ref1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(19)30290-X","article-title":"Dementia in China: Epidemiology, clinical management, and research advances","volume":"19","author":"Jia","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221100_ref2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer\u2019s disease facts and figures","volume":"18","author":"Alzheimer\u2019s Association","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221100_ref3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","journal-title":"Lancet"},{"key":"10.3233\/JAD-221100_ref4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.3233\/JAD-221100_ref5","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: A cross-sectional study","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.3233\/JAD-221100_ref6","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/brain\/awaa223","article-title":"Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain","volume":"143","author":"Drummond","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JAD-221100_ref7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-221100_ref8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13195-021-00772-0","article-title":"Invivo tau pathology is associated with synaptic loss and alteredsynaptic function","volume":"13","author":"Coomans","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-221100_ref9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer\u2019s disease: Towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221100_ref10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-221100_ref11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40265-015-0529-0","article-title":"Tau biology and tau-directed therapies for Alzheimer\u2019s disease","volume":"76","author":"Bakota","year":"2016","journal-title":"Drugs"},{"key":"10.3233\/JAD-221100_ref12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13195-021-00876-7","article-title":"Tau-related grey matter network breakdown across the Alzheimer\u2019s disease continuum","volume":"13","author":"Pelkmans","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-221100_ref13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"key":"10.3233\/JAD-221100_ref14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-221100_ref15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","article-title":"Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging","volume":"38","author":"Maass","year":"2018","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-221100_ref16","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","article-title":"Associations between tau, A\u03b2, and cortical thickness with cognition in Alzheimer disease","volume":"92","author":"Ossenkoppele","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-221100_ref17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-221100_ref18","doi-asserted-by":"crossref","first-page":"e1681","DOI":"10.1212\/WNL.0000000000012727","article-title":"Comparing the clinical utility and diagnostic performance of CSF P-Tau181, P-Tau217, and P-Tau231 assays","volume":"97","author":"Leuzy","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-221100_ref19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/alz.12236","article-title":"Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer\u2019s disease diagnosis","volume":"17","author":"Karikari","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221100_ref20","doi-asserted-by":"crossref","first-page":"e12921","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected","volume":"12","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-221100_ref21","doi-asserted-by":"crossref","first-page":"e20200861","DOI":"10.1084\/jem.20200861","article-title":"Blood plasmaphosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-221100_ref22","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-221100_ref23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221100_ref24","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12700"},{"key":"10.3233\/JAD-221100_ref25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat Med"},{"key":"10.3233\/JAD-221100_ref26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-221100_ref27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: A retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221100_ref28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer\u2019s Disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-221100_ref29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ana.26308","article-title":"Plasma p-tau231, p-tau181, PET biomarkers, and cognitive change in older adults","volume":"91","author":"Meyer","year":"2022","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-221100_ref30","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JAD-221100_ref31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41398-021-01476-7","article-title":"Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer\u2019s disease","volume":"11","author":"Chen","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-221100_ref32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","article-title":"Neuroimaging correlates of pathologically defined subtypes of Alzheimer\u2019s disease: A case-control study","volume":"11","author":"Whitwell","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221100_ref33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11910-019-1006-z","article-title":"Gray matter changes in Parkinson\u2019s and Alzheimer\u2019s disease and relation to cognition","volume":"19","author":"Krajcovicova","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-221100_ref34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer\u2019s Disease and aging","volume":"30","author":"Pini","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-221100_ref35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2006-9304","article-title":"Relationship of cognitive measures and gray and white matter in Alzheimer\u2019s disease","volume":"9","author":"Baxter","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221100_ref36","doi-asserted-by":"crossref","first-page":"825.e825","DOI":"10.1016\/j.neurobiolaging.2011.05.018","article-title":"Structural MRI changes detectable up to ten years before clinical Alzheimer\u2019s disease","volume":"33","author":"Tondelli","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-221100_ref37","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1002\/hbm.23772","article-title":"Gray matter asymmetries in aging and neurodegeneration: A review and meta-analysis","volume":"38","author":"Minkova","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"10.3233\/JAD-221100_ref38","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-221100_ref39","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0000000000001375","article-title":"Brain structure and function as mediators of the effects of amyloid on memory","volume":"84","author":"Mattsson","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-221100_ref40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/jpm11080702","article-title":"Brain atrophy mediates the relationship between misfoldedproteins deposition and cognitive impairment in Parkinson\u2019s disease","volume":"11","author":"Yu","year":"2021","journal-title":"J Pers Med"},{"key":"10.3233\/JAD-221100_ref41","doi-asserted-by":"crossref","first-page":"816043","DOI":"10.3389\/fnagi.2022.816043","article-title":"Correlation between brain structure atrophy and plasma amyloid-\u03b2 and phosphorylated tau in patients with Alzheimer\u2019s disease and amnestic mild cognitive impairment explored by surface-based morphometry","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-221100_ref42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221100_ref43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-221100_ref44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","article-title":"Cerebral blood flow in dementia","volume":"32","author":"Hachinski","year":"1975","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-221100_ref45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: A preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-221100_ref46","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221100_ref47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000341731","article-title":"Greater precision when measuring dementia severity: Establishing item parameters for the Clinical Dementia Rating Scale","volume":"34","author":"Lowe","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-221100_ref48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/WAD.0b013e31811ff2b4","article-title":"Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients","volume":"21","author":"Chaves","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-221100_ref49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ageing\/aft189","article-title":"The Hachinski ischemic scale and cognition: The influence of ethnicity","volume":"43","author":"Johnson","year":"2014","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-221100_ref50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S1041610296002505","article-title":"The Geriatric Depression Scale: A review of its development and utility","volume":"8","author":"Montorio","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-221100_ref51","doi-asserted-by":"crossref","first-page":"778123","DOI":"10.3389\/fnins.2021.778123","article-title":"The influence of MTHFR polymorphism on gray matter volume in patients with amnestic mild cognitive impairment","volume":"15","author":"You","year":"2021","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-221100_ref52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12021-016-9299-4","article-title":"DPABI: Data processing & analysis for (resting-state) brain imaging","volume":"14","author":"Yan","year":"2016","journal-title":"Neuroinformatics"},{"key":"10.3233\/JAD-221100_ref53","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jama.2021.14075","article-title":"A guideline for reporting mediation analyses of randomized trials and observational studies: The AGReMA Statement","volume":"326","author":"Lee","year":"2021","journal-title":"JAMA"},{"key":"10.3233\/JAD-221100_ref54","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jnnp.2008.154146","article-title":"Memory performance is related to amyloid and tau pathology in the hippocampus","volume":"80","author":"Reitz","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-221100_ref55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/sleep\/zsaa195","article-title":"Alzheimer\u2019s disease neuropathology in the hippocampus andbrainstem of people with obstructive sleep apnea","volume":"44","author":"Owen","year":"2021","journal-title":"Sleep"},{"key":"10.3233\/JAD-221100_ref56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/hmg\/ddx381","article-title":"Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Kandimalla","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-221100_ref57","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s40520-022-02148-2","article-title":"Plasma p-tau181 associated with structural changes in mild cognitive impairment","volume":"34","author":"Nabizadeh","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.3233\/JAD-221100_ref58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-221100_ref59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-021-01307-2","article-title":"Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels","volume":"10","author":"Wennstr\u00f6m","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-221100_ref60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-221100_ref61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fnagi.2019.00147","article-title":"Distinct brain regions in physiological and pathological brain aging","volume":"11","author":"Lee","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-221100_ref62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2018.01.024","article-title":"Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake","volume":"66","author":"Das","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-221100_ref63","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archneur.64.10.1489","article-title":"Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease","volume":"64","author":"Apostolova","year":"2007","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-221100_ref64","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1523\/JNEUROSCI.23-03-00994.2003","article-title":"Dynamics of gray matter loss in Alzheimer\u2019s disease","volume":"23","author":"Thompson","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-221100_ref65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-221100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:13Z","timestamp":1777370833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-221100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":65,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-221100","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]}}}